期刊文献+

动态检测外周血循环肿瘤细胞在晚期乳腺癌化疗中的意义 被引量:3

Significance of dynamic detection of peripheral blood circulatingtumor cells in chemotherapy for advanced breast cancer
下载PDF
导出
摘要 目的探讨动态检测循环肿瘤细胞(CTC)在晚期乳腺癌化疗中的意义。方法选择2018年11月—2019年12月本院收治的晚期乳腺癌患者52例作为研究对象,给予标准化疗方案,21天为1个疗程,分别于化疗前、化疗后1月、化疗后2月检测患者外周血CTC计数;另选择同时以良性乳腺肿瘤患者54例为对照组。结果晚期乳腺癌组与良性组外周血液循环中CTC个数存在显著性差异(P<0.05),且化疗前后CTC个数同样存在显著性差异(P<0.05)。结论动态检测外周血CTC对于乳腺癌患者的复发转移及晚期乳腺癌化疗疗效的验证有显著的意义。 Objective To explore the significance of dynamic detection of circulating tumor cell(CTC)in chemotherapy for advanced breast cancer patients.Methods Fifty-two patients with advanced breast cancer admitted to our hospital from November 2018 to December 2019 were selected and given standard chemotherapy regimen,with 21 days as a course of treatment.The peripheral blood CTC counts of patients were detected before medication,1 month after chemotherapy and 2 months after chemotherapy respectively,while 54 patients with benign breast tumors were taken as control group.Results Statistical analysis showed that there was significant difference in the number of CTCS in blood circulation between the advanced breast cancer group and the benign group(P<0.05),and there was also significant difference in the number of CTCS before and after chemotherapy(P<0.05).Conclusions Dynamic detection of peripheral blood circulating tumor cells is of great significance for the recurrence and metastasis of breast cancer patients and the verification of curative effect after chemotherapy for advanced breast cancer.
作者 张超 安程程 ZHANG Chao(The first affiliated hospital of Bengbu Medical College,Bengbu,Anhui,233004,China)
出处 《齐齐哈尔医学院学报》 2020年第12期1476-1478,共3页 Journal of Qiqihar Medical University
基金 蚌埠医学院校自然科学基金面上项目(BYKY1882)。
关键词 循环肿瘤细胞 晚期乳腺癌 化疗 Circulating tumor cells Advanced breast cancer Chemotherapy
  • 相关文献

参考文献9

二级参考文献45

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1571
  • 2鲍萍萍,郑莹,李新建,沈玉珍,向詠梅,金凡.利用GM模型分析上海市区女性乳腺癌和卵巢癌发病率[J].中国卫生统计,2005,22(5):299-300. 被引量:16
  • 3Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14):2137-2150.
  • 4Nkondjock A, Ghadirian P. Risk factors and risk reduction of breast cancer[J]. Med Sci (Paris), 2005, 21(2):175-180.
  • 5Salehi F, Dunfield L, Phillips KP, et al. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors[J]. J Toxicol Environ Health B Crit Rev, 2008, 11 (3-4):301-321.
  • 6Vo C, Carney ME. Ovarian cancer hormonal and environmental risk effect[J]. Obstet Gynecol Clin North Am, 2007, 34(4):687-700.
  • 7Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol.Ⅸ[M]. Lyon: IARC, 2007.
  • 8Lee JH, Yim SH, Won YJ, et al. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival[J]. J Korean Med Sci, 2007, 22 (Suppl):S11-16.
  • 9Chung HH, Hwang SY, Jung KW, et al. Ovarian cancer incidence and survival in Korea: 1993-2002[J]. Int J Gynecol Cancer, 2007, 17(3):595-600.
  • 10Marshall M, Solomon S. Hereditary breast-ovarian cancer: clinical findings and medical management [J]. Plast Surg Nurs, 2007, 27(3):124-127.

共引文献128

同被引文献18

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部